Please login to the form below

Not currently logged in
Email:
Password:

Envision Pharma acquires Alligent Biopharm Consulting

Aims to further optimise medical communications
Alligent Logo

Envision pharma has acquired Alligent Biopharm Consulting, a leading medical affairs agency that develops medical communications solutions for the biopharma industry.

The deal was supported by the Halifax Group, which partnered with Envision management to provide the equity investment to facilitate the acquisition. 

Brian Hepburn, CEO at Envision, said: “The addition of Alligent to the Envision Pharma Group further cements our core tenet of becoming the leading international medical affairs agency.

“By acquiring Alligent, we are able to expand the capabilities we offer to medical affairs teams to ensure optimal evidence communication and ultimate product adoption based on scientific rigor.”

Alligent's two principals, Joe Kohles and David Thompson in a joint statement, said: “Our focus on medical strategy, coupled with Envision's global presence and technology leadership position, offers the potential for us to expand and enrich our service breadth and offering to current and future clients alike.

“We look forward to joining the Group's leadership team and contributing to the continued success of both Alligent and Envision.” 

11th September 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Empowering the MS patient through shared decision making
Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered...
What pharma marketers can learn from Disney
Why we need to continue to innovate, and surprise our audience...
Good data is nothing without advocacy
...

Infographics